Charcot-Marie-Tooth (CMT) disease is a hereditary motor and sensory neuropathy characterized by similar phenotype despite genetic heterogeneity 1 . Charcot-Marie-Tooth type 1A, linked to a~1.4 Mb duplication containing the peripheral myelin protein-22 gene on chromosome 17p11.2, accounts for~50% of all CMT patients [2] [3] [4] [5] [6] . Disease severity varies considerably in CMT1A, however, the prototypical phenotype involves weakness and atrophy of distal limb muscles, distal sensory deficits and diminished deep tendon reflexes with symptoms appearing in childhood 7 . Interestingly, increased motor and sensory impairment is observed in CMT1A patients with diabetes 8 . Pes cavus, a skeletal deformity resulting from characteristic sparing of foot plantar flexors in combination with early weakness of dorsiflexors, is observed in approximately twothirds of CMT1A patients 7 . In contrast, mutilating foot deformities resulting from prominent distal sensory deficits are not typical of CMT1A, but have been associated with the 2B subtype of CMT disease and can be a feature of the Hereditary Sensory Neuropathies 9 . We present a patient who developed Charcot ankle, a destructive arthritis associated with peripheral sensory neuropathy, as a result of CMT1A augmented by type II diabetes mellitus.
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CASE
This 49-year-old man with type II diabetes mellitus for ten years was initially assessed by neurology for a benign headache. He was noted on examination to have classical findings of CMT disease, though he was unaware of the diagnosis. The patient had bilateral pes cavus and walked with a mild steppage gait, being able to clear his toes when walking without ankle splints. Moderate bilateral weakness of ankle dorsiflexion and eversion was accompanied by diminished patellar and absent Achilles reflexes. Sensory examination revealed diminished proprioception, vibration sense, and pin-prick perception distal to the ankle. The patient recalled experiencing numbness and deformity of both feet since early childhood. In addition, several family members (two maternal uncles, one brother and one maternal nephew) had been diagnosed with CMT disease. His mother had high foot arches, but had not been assessed for CMT.
Motor nerve conduction studies performed on the left median and ulnar nerves revealed a markedly diminished conduction velocity ( Charcot-Marie-Tooth 1A was diagnosed following detection of the characteristic peripheral myelin protein 22 locus duplication on chromosome 17. In this case, the duplication was detected by densitometry measurement of a probe designed to anneal to a diagnostic set of three alleles at the peripheral myelin protein 22 locus and by pulsed field gel electrophoresis.
The peripheral neuropathy proved to be a progressive process. Superimposed diabetic neuropathy was a concern, however, blood glucose was well controlled (7.3-7.5 mmol/L range) with the use of insulin. Within three years of presentation, he had lost all proprioception and vibration sensation distal to the ankles and had lower extremity areflexia. In addition, weakness and sensory deficits had appeared in his hands and neuropathic pain had developed in his legs which he described as "burning, hot sensations". Seven years after diagnosis, age 56, he had upper extremity areflexia, marked wasting of hand intrinsics, and sensory deficits extending both to the elbows and knees. Also noted at the seven year follow-up was a painful deformity of the right ankle.
The right ankle was warm and effused. In addition to his usual symmetric bilateral pes cavus, he had valgus deformity of the right ankle. X-ray indicated degenerative changes at the right ankle joint without evidence of fracture. There was anterior subluxation of the talus relative to the distal tibia and fibula with osseous fragmentation associated with the tibiotalar joint. There was diffuse subchondral sclerosis associated with the ankle joint and osteophyte formation in the vicinity of the medial and lateral malleoli. The degenerative process, suggestive of a neuropathic joint, progressed rapidly over the next three years ( Figures  A,B,C) . The patient developed complete hindfoot dissociation with severe ankle tilt and complete destruction of the talocalcaneal and talocrural joints. In summary, the foot was severely disfigured with a pes cavus midfoot, forefoot claw toes, and hindfoot dissociation. Conservative measures of non-weight bearing and orthotics were unsuccessful and he underwent a right ankle fusion and subtalar fusion, with significant improvement in symptoms ( Figure D) .
DISCUSSION
Charcot arthropathy is a destructive arthritis that develops in the context of a peripheral neuropathy involving loss of pain and/or proprioceptive sensation. Characteristic joint changes include degradation of articular cartilage leading to osteosclerosis, osteophyte formation, stress fractures, and erosion of joint surfaces 10 . The condition was first reported in 1703 as an arthropathy associated with advanced venereal disease 11 . Charcot joint is named after Jean-Martin Charcot who described the condition as a complication of tabes dorsalis 12 . Today, diabetes mellitus is the leading cause of a Charcot joint 13 . Though epidemiological data is weak, clinically overt Charcot joint is likely uncommon in large diabetes populations (incidence of 0.2 to 0.3%) 14, 15 , but more frequent in populations of diabetic neuropathy reported from subspecialty clinics and radiologic surveys of patients with diabetic neuropathy [16] [17] [18] . In this patient, it is impossible to differentiate aspects of sensory and motor dysfunction into discrete phenomena caused by diabetic neuropathy versus CMT1A. The development of diabetic neuropathy is strongly suggested by the appearance of "burning" sensations as CMT1A is not usually associated with neuropathic pain 7, 19 , though in mixed CMT populations neuropathic pain may be more common 20 . For most of his life this patient had a painless neuropathy typical of CMT1A. As well, the original clinical and electrophysiologic assessments were consistent with moderate expression of the typical CMT1A phenotype with the primary process one of demyelination rather than axonal degeneration, as might be seen in diabetic neuropathy 1 . Therefore, it is unlikely that diabetic neuropathy alone caused the Charcot ankle joint.
Charcot-Marie-Tooth 1A disease expression is highly variable, ranging from asymptomatic to severely affected at a young age, despite linkage of the disorder to an identical 17p11.2 chromosomal duplication 7 . Additionally, substantial variation in disease severity has been reported between identical twins 21 . This suggests the presence of modifying factors that influence disease phenotype. In patients with apparent severe phenotype from a young age modifier genes are likely necessary to explain variability. However, as additional risk factors for neuropathy arise, a non-genetic modification of the disease can develop 22 . Prior case reports have associated diabetes with severe neuropathy in CMT1A patients [23] [24] [25] . In at least one patient foot ulceration has been reported 25 . In a study of ten CMT1A patients with diabetes, neuropathy impairment as measured by the Charcot-Marie-Tooth neuropathy scale was more severe in the diabetic group (21.3±6.3) compared to age-matched controls with CMT1A alone (15.9±4.8) 8 . Motor impairment was significantly worse in CMT1A patients with diabetes while a trend toward increased sensory impairment in the diabetes group did not reach significance. The substantial increase in motor impairment is surprising as diabetes alone gives rise typically to a sensory dominated neuropathy.
Mutilating foot deformities, similar to diabetic sequelae, are frequently observed in CMT2B. In this subtype, significant sensory impairment leads to the development of foot ulcers and subsequent infection including osteomyelitis 26 . Other CMT subtypes have rarely been reported to induce deformity related to sensory deficit. Existing accounts are limited to isolated THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES 420
Figure: X-ray images of the right ankle demonstrate progressive degenerative changes due to Charcot arthropathy over a period of three years (A-C). Resultant functional impairment necessitated ankle and subtalar arthrodesis (D).
instances of CMT1 patients with acrodystrophic skin changes 7, 9 , spinal arthropathy secondary to CMT1 27 and neuropathic ankle joint in two patients with CMT disease following triple arthrodesis for correction of pes cavus 28 . In our case, diabetes may have contributed to the development of a severe CMT1A phenotype manifesting a Charcot foot joint.
The pathogenesis of Charcot joint has not been elucidated, however, neurovascular and neurotraumatic factors may contribute to the phenomenon. The neurovascular theory posits that altered autonomic control of the vasculature leads to increased bone-blood flow, initiating bone resorption and osteopenia 29 . The neurotraumatic theory proposes that insensate joints are subjected to repetitive trauma and extreme ranges of motion which results in inflammation and subsequent bone resorption 30 . While there may be a requirement for traumatic injury to joints prior to the development of Charcot joint, only 22% of patients recall an injury within one month of symptom onset 16, 31 . However, intrinsic muscle weakness due to a motor neuropathy may produce the initiating trauma as resultant eccentric loading of the foot with increased heel and plantar forces induces microfractures 32 . Significantly increased motor impairment in CMT1A patients with diabetes may contribute to foot instability and subsequent microfractures sufficient to induce a Charcot ankle joint. If this mechanism is correct then this case lends support to the neurotraumatic hypothesis for Charcot joint pathogenesis. Ultimately, this case illustrates that Charcot ankle arthropathy may develop in CMT1A if disease phenotype is modified by the presence of diabetes.
